Hairong Xu

1PUBLICATIONS
2CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Nov 26, 2025
JMT103 versus Non-Denosumab or Denosumab Treatment in Chinese Patients with Unresectable or Surgically Challenging Giant Cell Tumor of Bone: A Propensity Score-Matched Comparison.

Hairong Xu, Yong Zhou, Feng Wei

Pageof 1

Frequent Collaborators

1 joint publications

Weifeng Liu

1 joint publications

Xiaohui Niu